Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The guide explains how to study human and mouse sebaceous glands using various staining and imaging techniques, and emphasizes the need for standardized assessment methods.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Understanding glycans and enzymes that alter them is key to controlling hair growth.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

Certain transporters are found in human hair follicles and may affect hair growth and loss.

Blocking SCD1 in the skin with XEN103 shrinks sebaceous glands in mice.

Different human hair follicle stem cells grow at different rates and respond differently to a baldness-related compound.

Nicotinamide applied to the scalp can slow down hair growth.

Low-level laser therapy improves hair growth and dermal papilla cell function.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

New cell-based therapies may improve hair loss treatments in the future.

Scientists made structures that look like human hair follicles using stem cells, which could help grow hair without using actual human tissue.

Increased PPARGC1α relates to hair thinning in common baldness.

UV light helped human hair transplants survive in mice without broad immunosuppression.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

Scientists created complete hair-like structures by growing mouse skin cells together in a special gel.

Stem cells can be used to create long-lasting skin cells for treating pigment disorders.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

Plucked hair follicles can be used for regenerative therapies and personalized medicine.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Targeting EMT and fibrotic remodeling may help treat androgenetic alopecia.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

Sirolimus and propranolol may reduce abnormal cell growth and improve lymphatic malformations in children.

Hair loss in Lichen Planopilaris is caused by immune system issues damaging hair follicles and stem cells.

Pregnancy can cause symptoms similar to rheumatic diseases, making diagnosis difficult, and affects various body systems, requiring careful distinction between normal changes and serious conditions.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Low-level Laser Therapy may help reduce inflammation, pain, and aid healing, but more research is needed to confirm its effectiveness and establish standard treatment guidelines.

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

Human hair follicle organ culture is a useful model for hair research with potential for studying hair biology and testing treatments.

PPAR-γ agonists like pioglitazone may help manage lichen planopilaris but don't fully reverse scarring.